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1 Introduction 
Cost measurement can be roughly defined as measuring resource consumption, in terms of dollars, for a 
given medical intervention. Cost measurement in health care has become increasingly popular in recent 
decades and shows no signs of abating; a critical look at current trends is available in Triplett (1999). 
This trend of measuring costs results from society's willingness to pay for health care interventions. 
Given budgetary constraints, we must wisely allocate resources in order to maximize health benefits 
for individuals. Gaining insight into patient-level factors that affect the cost of medical interventions is 
therefore crucial if we are to devise cost-effective strategies for prevention and intervention. 
This paper is concerned with the problem of modeling lifetime (i.e., cumulative) medical costs measured 
from some well-defined point of patient entry (e.g., start of treatment) to some well-defined event (e.g., 
death). In follow-up studies with finite time horizons, it is inevitable that some individuals under study 
are censored prior to observing the event of interest. In such cases, lifetime costs are also censored, and an 
important issue emerging in the biostatistics literature is the proper handling of such data. In particular, 
even in cases where censoring on the time scale is purely administrative (i.e., random), censored lifetime 
cost endpoints are subject to "induced" informative censoring. Lin et al. (1997) describe this problem 
in the context of patient-level cost functions. Individuals who accrue costs at higher (lower) rates will 
tend to have larger (smaller) cumulative costs at both censoring and event times. Consequently, the 
transformation of time by the individual cost functions induces dependence between the respective values 
of the cost process at the censoring and event times. This dependence exists even if the censoring and 
event times are themselves independent. 
Similar problems arise in other settings involving endpoints that may be viewed as random transforma-
tions of survival times. For example, Gelber et al. (1989) discuss the dependence between the censored 
and uncensored quality-adjusted lifetime measure TWiST. Zhao and Tsiatis (1997) formulate and solve 
a related problem that deals with the nonparametric analysis of quality-adjusted survival time data. In 
fact, problems of induced informative censoring occur naturally in cases where the process of interest 
(e.g. cumulative cost) is increasing over time and its observation is stopped due to the occurrence of 
a possibly dependent terminal event (Strawderman, 2000). In such cases traditional survival analysis 
tools (e.g., Kaplan-Meier, Cox proportional hazards models, etc ... ) that assert independence between 
censoring and the outcome variable are no longer appropriate. 
A handful of statistical methods appropriate for dealing with lifetime cost data, and more generally re-
sponse variables subject to induced informative censoring, have been proposed. Essentially all published 
work has dealt with the problem of non parametric estimation, ignoring important covariate information; 
see, for example, Lin et al. (1997), Zhao and Tsiatis (1997), Cook and Lawless (1997), van der Laan and 
Hubbard (1999), Bang and Tsiatis (2000b), and Strawderman (2000). Considerably less work has been 
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done leading to valid estimators that adjust for patient covariate information. Bang and Tsiatis (2000a) 
consider median regression for lifetime cost data assuming censoring is independent of all else, includ-
ing covariates. Lin (2000a) considers proportional-means regression models under similar assumptions. 
Lin (2000b) considers direct extensions of the linear regression model, and allows censoring to further 
depend on covariates. The fundamental difference between Lin (2000a) and Lin (2000b) is whether one 
prefers to allow for multiplicative versus additive covariate effects on lifetime costs. All of the methods 
proposed thus far entail restrictive assumptions regarding the relationship between lifetime cost and 
covariate information. 
In this paper we focus on modeling the lifetime cost distribution as a function of patient covariates. 
Kooperberg, Stone, and Truong (1995a) develop and implement hazard regression (HARE) modeling 
for noninformatively censored data by modeling the log hazard function using linear splines and their 
tensor products. We adapt their approach to informatively censored lifetime cost data by employing 
appropriate "inverse probability of censoring weighted" (IPCW) estimating equations derived from those 
of the original HARE model. This modeling paradigm, referred to as IPCW-HARE, proves versatile 
in its lack of restrictive assumptions (e.g., proportional hazards, a linear relationship between survival 
time and covariates, etc ... ) and in its user-friendly software implementation. Further development and 
discussion of issues unique to IPCW-HARE are given in Section 2. A fundamental difference between 
IPCW-HARE and the methods of Lin (2000a,b) and Bang and Tsiatis (2000a) is that we have elected to 
model the conditional distribution function of lifetime cost given covariates rather than a single summary 
measure (e.g., mean or median cost). This approach affords certain advantages. For example, in addition 
to being able to compute various summary measures (e.g., mean or median costs), one may gain further 
insight by exploring the conditional hazard, density, and cumulative distribution function of costs for 
different covariate patterns. In Section 3, we evaluate the utility of IPCW-HARE for estimating mean 
and median costs using simulation and compare our results to the estimated mean and median costs 
respectively obtained using the methods of Lin (2000b) and Bang and Tsiatis (2000a). Finally, in Section 
4 we analyze some cost data associated with two common modes of dialysis for Medicare patients with 
end-stage renal disease. 
Although we focus here on modeling lifetime medical cost data, the present framework extends without 
alteration to other settings involving continuous outcomes. For example, our methods can be used for 
quality of life studies, where censoring induces a dependence between the censored outcome process 
and the actual outcome (e.g., Zhao and Tsiatis, 1997). However, because the focus is on modeling the 
hazard function of an absolutely continuous random variable, the methods to be discussed here are not 
appropriate for discrete outcomes. Thus, for example, the present modeling framework would not be 
appropriate in the recurrent event setting considered by Cook and Lawless (1997) since the lifetime 
cumulative number of events is a discrete outcome variable. 
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2 HARE and its IPCW extension 
2.1 Notation and Assumptions 
In order to discuss the notion of "lifetime cost", we must first define a notion of "lifetime". Similarly to 
Lin (2000a,b), we assume interest lies in costs accrued over the period [0, L], where L < oo. Patients may 
experience a terminal event U (e.g., death) prior to L, and we shall subsequently interpret "lifetime" as 
being the minimum of these two times. More precisely, let T = min(U, L) denote "lifetime", and define 
the "lifetime cost" V to be the cost accumulated over [0, T]. Evidently, V is the terminal cost if U:::; L 
and is (say) the £-year cost otherwise. The role of L, as well some restrictions on its selection, are 
discussed further in the last paragraph of this section. 
As described in the Introduction, the event T, hence V, will not be observed for all patients. For a 
given patient, let C and D respectively denote a potential censoring time and corresponding censored 
value of lifetime cost. We suppose that (i) if T :::; C, then V :::; D; and, (ii) if T > C, then V > D. 
A standard convention in survival analysis is that only X = min(T, C) and 6. = I {T :::; C} may be 
observed for a given patient. Consequently, observable data on any given patient are assumed to take 
the form (Y, X, 6., Z), where Y = min(V, D) and Z represents a vector of baseline covariates. Note in 
particular that 6. serves as the censoring indicator for both lifetime and lifetime cost. Our observed data 
are assumed consist of a random sample of the form (Yi,Xi,6.i,Zi), i = 1 . .. n. 
We have chosen to model the hazard function of V given Z; hence, it is explicitly assumed that V is a 
continuous random variable. For simplicity, it is further assumed that (1) T and C are also continuous 
random variables; (2) the covariates Z are bounded; (3) T and Care independent given Z; and, ( 4) V and 
Care independent given Z. Importantly, however, no assumptions are made regarding the dependence 
between T and V or T and Z. Technical considerations further dictate that L must satisfy K(LIZ) > 0 
with probability one, where K(ciz) = P(C > ciZ = z). To better understand this condition, suppose 
L were equal to the largest possible terminal event time U (i.e., L = sup{t : P{U > t} > 0}) and 
that K(Liz) = 0 for all possible realizations z of Z. This implies all patients are censored prior to 
L; consequently, without further assumptions on the rate at which costs accrue over time for different 
patients, it would be impossible to estimate the total cost on [0, £]. 
2.2 HARE: A Brief Review 
Kooperberg et al. (1995a) propose a hazard regression (HARE) model for positive, right-censored time-
to-event data. In particular, they assume 
p 
log>.,13(vlz) = L,BjBj(viz)I{v > 0}, 
j=l 
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(1) 
where \a(vlz) denotes the conditional hazard function for the uncensored outcome variable (e.g., V), 
B 1 .•. Bp form a basis for a space of functions defined in V and Z, and (3i is the regression coefficient 
associated with the jth basis function. Essentially, the functions Bj, j = 1 ... p together define linear or 
spline functions of the outcome and/or continuous covariates, linear functions of categorical covariates, 
and two way interactions. A full description of the basis, as well as the space of functions spanned by 
(1), can be found in Kooperberg et al. (1995a, §5). The HARE model (1) is exceptionally flexible in its 
use of piecewise linear splines and does not apriori make restrictive assumptions about the relationship 
between V and Z (e.g., proportional hazards). Notably, the HARE model does contain the (parametric) 
proportional hazards model as a special case since, under (1), .A_a(vlz) = >..0 (v)g(z) (say) if none of the 
basis functions Bj(vlz) simultaneously depend on v and z. 
Kooperberg et al. (1995a) fit (1) to randomly right-censored data using maximum likelihood, the relevant 
partial likelihood being 
n II >...a(YiiZi)~i F!J(YiiZi), (2) 
i=l 
where Fp(ylz) is the survivor function associated with the hazard function >.p(ylz). Employing a notion 
of "allowable spaces", they utilize a stepwise addition and deletion procedure for choosing basis functions 
that represents a hybrid of well-known stepwise addition and deletion procedures appropriate for linear 
and generalized linear models. The Bayesian Information Criterion (BIC; see Schwarz, 1978) is used 
to select the final model from the sequence of fitted models. We refer the reader to Kooperberg et al. 
(1995a) for further details regarding the model fitting and selection procedures, and Kooperberg, Stone, 
and Truong (1995b) for some relevant asymptotic theory. 
2.3 IPCW-HARE: HARE for informatively censored data 
The likelihood (2) is valid assuming censoring is noninformative. As discussed earlier, this assumption 
is violated when analyzing censored lifetime cost data. In particular, if one applies HARE directly to 
the observed data (Yi, Xi, 6.i, Zi), i = 1 ... n, an inconsistent estimate of the hazard function, hence 
desired summaries (e.g., means, medians, etc ... ), is the likely result. In this section, we propose a 
modification of HARE in order to account for the informatively censored nature of lifetime medical cost 
data. Importantly, the model (1) is not being changed; rather, the method by which (1) is estimated is 
what requires modification. 
To motivate the basic IPCW-HARE estimating function, suppose there is no censoring. Then, the 
contribution of the ith individual to the loglikelihood function for (3 = ((31 ... (3p) T takes the following 
exponential family form (Kooperberg et al, 1995a): 
(3) 
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for Yi ~ 0; note that Yi = Vi here since we have assumed there is no censoring. The resulting score 
vector contribution is si ((3) = (Si1 ((3) 0 0 0 Sip ((3)) T, where 
du. (4) 
Based on a random sample of size n, the MLE of f3 is obtained via the score equation Stuu(/3) = 
2:::~= 1 Si ((3). In the missing data literature, S full ((3) is generally referred to as the "full data" score 
function, an appropriate characterization since it is derived from the full data (V, T, Z). Obviously, the 
MLE of f3 cannot be computed via Stuu(/3) in the presence of censored data. 
In a rather general missing data setting, Robins and Rotnitzky (1992) propose to construct estimating 
functions from complete observations by inversely weighting "full data" contributions by the respective 
probability of being observed. In the context of the present problem, and assuming that our observed 
data take the form (Yi, Xi, 6.i, Zi) i = 1 ... n, a valid IPCW estimating equation for f3 is 
(5) 
the normalization of n-1 being used for notational convenience only. By reweighting score contributions 
using this IPCW scheme, we are calculating an M -estimator for f3 that accounts for the informatively 
censored nature of the data. In fact, under mild conditions, (5) is easily shown to be an unbiased 
estimating function for (3; see, for example, Robins and Rotnitzky (1992). 
Since K(·!·) is generally unknown, an estimate of K(·!·) must be substituted into (5) in practice. In 
the case where the censoring process is not influenced by covariates (e.g., administrative censoring) this 
is easy to do using the Kaplan-Meier estimator. If censoring does depend on covariates then a model 
must be chosen. A simple and attractive choice here is to assume that the censoring mechanism follows 
a Cox proportional hazards model. In addition to being widely used and well understood, this model 
contains the important case of independent censoring. Whatever estimate of K(·!·) the user employs, 
the resulting estimating function takes the form 
-1 ~ L\i Sipcw ((3) = n L....t ~ Si (!3), 
i=1 K(Xi!Zi) 
(6) 
and the estimate jj is that which solves Sipcw(f3) = 0. Since (5) and (6) coincide when K(·!·) = K(·!·), 
we only consider (6) from this point forward. 
The estimating function (6) forms the core of IPCW-HARE, and replaces the score function derived 
from (2) that is used by HARE. We now briefly outline some relevant asymptotic properties of 7J. 
Precise statements of regularity conditions are purposely avoided since the asymptotic results provided 
below do not account for the data-driven fitting procedures employed by IPCW-HARE and thus are not 
useful for statistical inference. Rather, these results are used primarily in §2.4, where some important 
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changes to the model building and model selection criteria originally employed by HARE are discussed 
in detail. These changes represent a necessary consequence of the move away from a maximum likelihood 
estimation framework. 
Suppose the set of basis functions Bj(·l·), j = 1 .. . p, hence the dimension of the parameter space, 
is fixed and finite. Let (3* E IRl be the unique maximizer of the strictly concave function E[£1 (/3)] 
with £1 (/3) being given by (3). In the appendix, consistency of fi for (3* is established provided the 
estimated weights satisfy certain consistency conditions. Let SipcwC/3) denote the derivative of Sipcw(/3) 
with respect to /3, and suppose that -SipcwC/3*) ~ M(/3*), where M = M(/3*) is nonsingular. Then, 
under suitable conditions, it follows that 
where Q is the asymptotic variance of (6) at /3*. This result holds whether or not K(·l·) is estimated 
from the data, with the effect of estimating K (·I·) being entirely reflected through Q. Specifically, if 
K(·l·) is known, 
in contrast, when K(·l·) is estimated from the data, the actual form of Q depends on the model and 
method used for estimating K(·l·). In the appendix, a specific formula for Q is devised for the case 
where K(·l·) follows a (semiparametric) Cox proportional hazards model and is estimated accordingly. 
The criteria used by IPCW-HARE in building models are discussed in detail in the next section. These 
criteria depend in part on the assumed asymptotic behavior of {3, and in particular on the matrices Q and 
M. The contrast in asymptotic behavior that results from knowing versus estimating K(·l·) has some 
important practical implications. Specifically, suppose first K(·l·) is regarded as an estimated quantity. 
Then, the dependence of Q on the model for the censoring mechanism implies that different censoring 
models (e.g., a semiparametric versus fully parametric Cox proportional hazards model) necessitate 
completely separate implementations of IPCW-HARE. Such dependence further rules out the use of 
HARE and other data-adaptive methods for estimating K(·l·) since their asymptotic behavior cannot be 
characterized precisely. The situation changes dramatically when K(·l·) is regarded as a known quantity 
(i.e., treated as known, even if it is estimated). In particular, since Q no longer depends on the assumed 
model for K(·l·), it may be estimated using Q = n-1 'f:.i{i;i{i;[, where {i;i = K(:.;IZ;)Si({j). Because 
computation of Q only requires the estimated weights (i.e., as opposed to knowledge of the model that 
generated them), the same implementation of IPCW-HARE may be used however K(·l·) is estimated. 
For a fixed set of basis functions, the implications of treating the estimated quantity K(·l·) as known 
are clear: while the consistency of (j is unaffected, fixed-size tests and fixed-level confidence sets will 
respectively have incorrect size and coverage. The decision rules employed by IPCW-HARE during the 
model building process do not rely on formal tests of significance or fixed level confidence sets, and 
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Kll·) is in fact held fixed throughout the entire model-building phase. Consequently, in the context 
of adaptively building a model for a given dataset, the need to acknowledge the fact that K(·l·) is 
estimated is less clear. Moreover, the possible limitations that result from ignoring the fact that K(·l·) 
is estimated are offset by very substantial practical gains. For example, in addition to allowing the user 
to employ any reasonable method for estimating K(·l·), tremendous gains in computational efficiency 
are realized. Since standard errors will be computed via nonparametric bootstrap (i.e., resampling 
(Yi, Xi, .6-i, Zi), i = 1 ... n with replacement), such gains in computational efficiency become important, 
particularly for large datasets. Bootstrapping is also advantageous since the standard deviation estimates 
reflect both estimation of the weights and the adaptive model selection scheme. 
2.4 IPCW-HARE: Important modifications to HARE 
Despite our reweighting of the HARE score equations, many of the procedures described in Kooperberg 
et al. (1995a) used for fitting (1) to data (e.g., knot placement, starting values, etc ... ) were able to 
be utilized by IPCW-HARE without significant alteration. However, some important modifications to 
HARE were also required. Essentially, these modifications were needed in two places: adding and deleting 
basis functions and selecting the "best" HARE model. For reasons discussed earlier, our particular 
implementation of IPCW-HARE treats K(·l·) as known for the purposes model building; consequently, 
0 - I ~ ~ ~~T ~ .6.· ~ 
m what follows we employ M = -SipcwUJ) and Q = n-1 Li 1/Ji'I/Ji , where 1/Ji = K(X;IZ;) Si(/3). The 
changes to be described below drastically reduced the incidence of overfitting (i.e., the propensity of 
HARE to fit the model to extreme data points), and as our simulation results will show, yield estimators 
with good overall performance. 
2.4.1 Stepwise Addition and Deletion of Basis Functions 
During the addition phase of the model building process, HARE attempts to enrich the class of hazard 
functions covered by (1) by moving from (say) a p-1 dimensional "allowable space" G0 to a p dimensional 
allowable space G that contains G0 • In practical terms, this is handled by adding a candidate basis 
function Bp, hence coefficient /3p, to the model. At any given step, there are a potentially large number 
of candidates; consequently, due to the computationally intensive nature of the fitting process, HARE 
cannot refit the model and compare loglikelihoods like one might do with a generalized linear model. 
Instead, HARE "tests" the hypothesis that (1) is a member of G0 using a Rao statistic, and in particular 
adds the basis function which maximizes this statistic (or minimizes the p-value). Kooperberg et al. 
(1995a, §4) provide further details. 
Like HARE, IPCW-HARE starts with a constant hazard function and adaptively builds a sequence of 
larger models. The version of the Rao statistic used by HARE is not really appropriate for use by 
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IPCW-HARE because it uses the inverse information matrix as an estimate of variance. Let jj0 denote 
the solution obtained by setting (6) equal to zero for the model corresponding to G0 . Suppose the test 
we are conducting is for f3v = 0. Let Sa(f3) denote (6) for a candidate hazard model corresponding to 
space G, let -Ma(f3) be its first derivative, and let Qa(f3) denote an estimate of Var[Sa(fJ)]. Finally, 
let Sav(f3) denote the pth element of Sa(f3). Then, the Rao statistic we use in deciding whether or not 
to add a basis function is 
2 ~ T~-1 ~ T R = nSav(f3o) C Sav(f3o) , 
where lJo = (jj0 , O)T and Cis computed via (5) of Heritier and Ronchetti (1994) with (in their notation) 
M = Ma(ffo) and V = Ma 1 (ffo)Qa(ffo)M01 (ffo). The basis function added at a given step is then that 
with the largest value of R 2 . The Rao statistic R2 reduces to that used by HARE if V = M-1 , as would 
be the case under maximum likelihood estimation. 
Kooperberg et al. (1995a, §11.4) list 3 criteria used by HARE for deciding whether to continue adding 
basis functions. Two of these have clear practical justifications; the last essentially corresponds to a 
likelihood-ratio-based criterion for assessing improvement in model fit. Specifically, suppose the present 
model has P basis functions. Then, HARE stops adding basis functions if 2(Cp -fv) < (P- p) - 1 
for some p with 2 ~ p ~ P- 3, where fp and Pp respectively represent the (estimated) loglikelihood 
for a model with P and p basis functions. Since the fitting process ensures that the model with p basis 
functions is nested within the model with P basis functions, 2(fp -Pp) is approximately distributed as 
x1:.-v (i.e., assuming that the model with p basis functions is sufficient). Thus, HARE discontinues the 
addition phase if the change in loglikelihood values does not exceed its mean value (minus one). 
REMARK: Asymptotically, HAREs criteria boils down to unnecessarily adding a basis function with 
probability P {x}._P > P - p - 1}. Since P - p 2: 3, it is easy to show that this probability is at most 
0.57, and monotonically decreases to 1/2 asP- p get large. Hence, the decision to add a basis function 
when it is in fact not needed is roughly equivalent to tossing a (slightly) biased coin. 
Since IPCW-HARE is not maximum likelihood, HAREs particular criteria for assessing model fit carries 
questionable relevance. Let £i(jj<vl) and £i(jj<Pl) denote the contribution of patient i to the full data 
loglikelihood (3) for nested models respectively having p and P basis functions; note that these are to 
be interpreted in a similar manner to Pp and fp. Consider the likelihood-ratio-type statistic 
see, for example, Heritier and Ronchetti (1994, eqn. 6). If K(·l·) were known, L; could be derived as the 
likelihood ratio statistic assuming the data follow a density proportional to exp( -T(Y, X,~' Z, (3)), where 
T(Y,X,~,Z,/3) = ~£(/3)/K(XIZ) and £(/3) is computed similarly to (3) (cf. Ronchetti, 1997, §3.1). 
Consequently L; represents a reasonable statistic for assessing improvement in model fit. However, 
the (asymptotic) mean of this statistic is not P - p. In fact, under suitable conditions, L; behaves 
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asymptotically like a finite mixture of xi random variables, the mixing coefficients being governed by 
the eigenvalues of a certain matrix depending on Q and M defined in Section 2.3 above; see Heritier and 
Ronchetti (1994, §2 and Proposition 3a) for further details. Analogously to HARE, the criteria we use 
for stopping the addition of basis functions is L;, < /iP-p- 1, where /iP-p denotes an estimate of the 
mean of the appropriate mixture of chi-square random variables. 
Finally, upon stopping stepwise addition using the rule described above, we begin stepwise deletion. The 
decision rule for keeping the pth basis function is based on the Wald statistic 
~2 
w2 = ~p 
Vpp 
where V = n-1 M01 (-g)Qa(-g)M01 (fj) and -g is the solution to (6) under model G. In particular, for a 
given model dimension, the basis function corresponding to the smallest value of W 2 is deleted. Similarly 
to the stepwise addition phase, this criteria reduces to that used by HARE if Ma = Qa, and the process 
of deleting basis functions is continued until the smallest possible model is reached. 
2.4.2 Model Selection 
The stepwise process of adding and deleting basis functions creates a sequence of models for the hazard 
function, one of which must be selected. HARE employs the Bayesian Information Criterion (BIC; see 
Schwartz, 1978) for this, and chooses between models using penalized comparisons between loglikeli-
hoods. For reasons similar to those described in the last section, a modification is employed due to the 
absence of an appropriate likelihood. Ronchetti (1997) develops a Robust Akaike Information Criterion 
(AICR) for theM-estimator setting. Let -g denote the parameter estimate obtained under a given model, 
and consider (cf. Ronchetti, 1997, eqn. 3.2) 
~ ~i ~ - ~ AICR = 2 ~ ~ · l!i(/3)- a 1og(nu)tr(M-1Q), 
i=l K(XiiZi) 
where M and Q denote estimates of M and Q evaluated at -g, nu denotes the number of uncensored 
observations, and a is a fixed multiplier. Roughly speaking, the role of AICR is similar to BIC, and 
model selection by IPCW-HARE is carried out by selecting the model with the maximum value of AICR, 
the default choice of a being 1. The use of log(nu) as the penalty parameter is meant to emphasize the 
fact that the amount of information present in censored data substantially depends on the number of 
uncensored observations rather than total sample size. 
3 Simulation Results 
To evaluate the performance of IPCW-HARE we conducted Monte Carlo simulations with various life-
time cost schemes. IPCW-HARE approximates the hazard function of the cost variable as a function of 
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covariates; for simplicity we report only the mean and median lifetime cost estimates derived from this 
hazard estimate for specific covariate patterns. We fit restricted models, in which no covariate-by-cost 
interactions are allowed (i.e., proportional hazards, or PH=T); we also fit unrestricted models (PH=F) 
in which covariate-by-cost interactions are allowed. Importantly, in none of our examples is there an ob-
vious "true" model, meaning that the resulting data generation scheme is in exact correspondence with 
a member of the parametric family of models we are working within. Hence, in each case the hazard (1) 
at best represents an approximation to reality, and these simulation results constitute an illustration of 
the "real world" performance of the IPCW-HARE procedure. 
Since a nice analytic expression for the mean cost under the IPCW-HARE model is not available, we 
estimate this using Monte Carlo. In particular, for a given hazard function estimate, we generate 2,000 
random lifetime cost observations using HAREs built-in function rhare, and then take a simple average 
of these to obtain our Monte Carlo estimate of the mean lifetime cost. To estimate the median cost, we 
again use the built-in functionality of HARE by employing the qhare function provided with the original 
HARE software. The censoring weights are computed using the product-integral form of the survivor 
function appropriate for a Cox regression model; see Andersen et al. (1993, eqn. 7.2.34) for details. All 
simulations employ 2,000 replicated datasets of size n = 200. 
Our first simulation is adopted from Bang and Tsiatis (2000a). Survival and censoring times (in years) 
respectively follow Uniform[0,10] and Uniform[0,12.5] distributions. We set L = 10 years, which leads 
to approximately 40% censoring. A single covariate Z is assumed Uniform[20,70]. The cost function 
for an individual i consists of a one-time baseline diagnostic cost Boi, an annual cost Bij uniformly 
distributed throughout each jth year, and a death cost Di uniformly distributed over the last year 
of life. Specifically, Boi = 500 + lOOZi + Ei, Bij = 400 + 10Zi + c:~i, and Di = 1000 + 200Zi + c:~1 
where C:i is Uniform[2500,7500], c;~j is Uniform[500,1300], and c~1 is Uniform[5000,15000]. Notice that the 
covariate only affects cost, and does so linearly; survival and censoring variables do not depend on this 
information. Although censoring is independent of the covariates, the weights are still estimated using a 
Cox proportional hazards model with Z as the lone covariate. In order to assess the effect of including 
weights (and hence of informative censoring on cost), we have included results obtained from fitting the 
original (i.e., unweighted) HARE model to these data for comparison. Finally, we have also included the 
estimators of Lin (2000b) and Bang and Tsiatis (2000a), which ought to perform very well here due to 
the structure of the cost function. 
The results of the first simulation are summarized in Tables 1 and 2. IPCW-HARE is seen to perform 
well in estimating both mean and median lifetime cost across the range of Z. In contrast, HARE 
demonstrates a substantial negative bias for all covariate patterns, the largest bias being on the order 
of $1,900. Consequently, there is a significant (and predictable) effect of informative censoring in this 
example. The fact that IPCW-HARE leads to more variable estimates is expected; HARE uses both 
11 
censored and uncensored cost observations, while IPCW-HARE only uses uncensored cost observations. 
Consequently, HARE, though biased, makes more efficient use of the available data. The estimators of 
Lin (2000b) and Bang and Tsiatis (2000b) generally outperform those produced by IPCW-HARE for 
respectively estimating the mean and median costs. This is also to be expected since these methods are 
specifically designed for estimating the effects of covariates with a linear relationship to lifetime cost. 
Finally, it is seen that the allowance for interactions between cost and covariates makes little difference 
in the IPCW-HARE estimates, indicating a proportional hazards assumption is reasonable here. 
The first simulation assumed costs accrue uniformly on a yearly basis, and that costs increase linearly as 
a function of a single covariate. In our second simulation, we instead allow the cost-incurring episodes 
to occur at random times; that is, we assume recurrent events with associated costs. The first covariate 
zli is Uniform[10,50] and the second covariate z2i is Bernoulli with p = ~. Given zli = Zl' survival 
times are Gamma distributed with a conditional mean of ~; z1 years; the unconditional mean survival 
time is 12 years. Censoring times are Exponential with a mean of 18 years and L=15. Conditional 
on failure time and covariate information, the recurrent events follow a homogeneous Poisson process 
with rate .\(s/Ti = t, Zli = zl) = 0.01 · z1 ·log(max(3, t)) and the cost of each event is distributed as 
Uniform[$2000,$5000]. Initial costs for patients, or Boi, are assumed Uniform[$0,$5000] if Z2i = 0 and 
Uniform[$5000,$10000] if Z2i = 1. Finally, given Zli = z1, the death cost Di is $10000 Uniform[1,j(z1)] 
where f(zl) = .JZJIO E (1, 2.24), and is uniformly distributed over the last two years of life. This 
leads to an average of 7.6 cost-incurring episodes per patient over the course of their (truncated) lifetime 
and 34% censoring. Importantly, the covariate Z2 affects baseline costs only, and does so linearly; the 
covariate Z1 affects both survival and cost in a nonlinear way. Censoring is independent of the covariate; 
however, the weights are estimated using a Cox proportional hazards model based on both Z1 and Z2 . 
The results of the second simulation are given in Tables 3 and 4. The mean and median of the covari-
ate Z1 both occur at 30. Comparing the IPCW-HARE models "PH=F" versus "PH=T", we see the 
former tends to exhibit substantially less bias, indicating proportional hazards may not be a reasonable 
assumption. Across the range of Z, IPCW-HARE (PH=F) is seen to outperform the simple regression-
based estimators for estimating both mean and median costs. Although the Bang and Tsiatis (2000a) 
estimator does very well for zl = 15, its performance degrades significantly as zl' hence the level of 
censoring, increases. Comparing Table 4 and Table 2, we further see that the efficiency gains of these 
regression methods over IPCW-HARE are significantly reduced when the true cost function and linear 
regression model fail to coincide. 
In our third and final simulation, we move away from the previous two paradigms and simulate lifetime 
cost directly. That is, we employ a model to generate only the lifetime cost v,;, rather than computing 
it indirectly via accumulating intermediate costs. We also allow for both survival and censoring to 
depend on relevant covariates. The covariate Zli is Uniform[10,70] and Z 2i is Bernoulli with p = ~- If 
12 
10 :S Zil < 30, the survival time U; is Exponential with mean 20 years; if 30 :S Zil < 50, U; is Exponential 
with mean 15 years; and if 50 :S Z;1 :S 70, U; is Exponential with mean 10 years. The censoring time 
C; is Exponential with mean 25Z2; + 18(1- Zz;) years. We set L=25 and T; = min(U;, L). This leads 
to approximately 39% censoring overall. Finally, the terminal cost Vi is assumed to follow a Gamma 
distribution with mean a(Z;)(3(T;, Z;) and standard deviation J a(Z;)(3(T;, Z;). The shape parameter 
a(Z;) = ~Z2;Z[;+ i (1-Z2;)Z[; and the scale parameter (3(T;, Z;) = Z2i log(1+T;)+2(1-Z2;) log(1 +T;). 
This implies, given T; and Z;, that the average cost equals ~(2- Zz;) 2 Z[; log(1 +T;) and that the standard 
deviation equals )3(2- Z2;) 312 Z1; log(1 + T;). Consequently, mean lifetime costs generally rise (and 
become more variable) as Z1; rises; the rates at which these costs rise (and their level of variability) 
depends on Z2;. Consequently, there is a rather complicated interaction between the effects of Z1 , Z2 
and T on the terminal cost V. 
The results of the third simulation are given in Tables 5 and 6. In terms of bias, IPCW-HARE performs 
very well in estimating both mean and median lifetime cost across the various covariate combinations. 
In contrast, the linear regression models perform rather poorly, in some cases having enormous bias. 
In fact, for the covariate combination (15,1), these regression models led to negative simulated average 
mean and median lifetime costs. To be fair, these linear regression methods might perform better if, for 
example, costs were placed on the log scale, interaction terms were placed in the model, and nonlinear 
covariate effects were allowed. This was not done to better illustrate the point that IPCW-HARE is able 
to produce reasonable estimates with much less preliminary analysis. 
This suite of simulations suggests that IPCW-HARE performs well under a variety of situations, and 
show in particular that (i) IPCW-HARE-based estimates tend to be less biased than those obtained 
using methods that impose stronger assumptions; and, (ii) this increase in accuracy usually comes at 
some expense in precision. Our results also indicate that the ignoring the censored cost observations 
entirely probably entails a significant loss in precision (i.e., see Table 2); we return to this issue in the 
Discussion. We suspect that some portion of the residual biases observed in Tables 1, 3, and 5 are a result 
of model misspecification. Specifically, despite being adaptive, IPCW-HARE eventually yields estimates 
able to accurately approximate functions that lie within some restricted class only. Consequently, in 
finite samples model misspecification is still an important consideration. Reducing such bias should be 
possible by increasing the flexibility of the basis; for example, by employing using cubic instead of linear 
splines. 
4 End-Stage Renal Disease Data 
The data consist of subjects with End-Stage Renal Disease (ESRD) collected from the United States 
Renal Data System (USRDS). Individuals were included in the study if they started peritoneal dialysis 
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or hemodialysis within the window of January 1, 1992 thru December 31, 1996. All subjects are 66 
and older, have Medicare as a primary payer, and are possibly censored due to loss-to-follow-up, end 
of study (12/31/96), or kidney transplant. Available covariates include age at the start of treatment 
(66-70, 71-75, and > 75), gender, whether diabetes is the primary cause of ESRD, and race (white, 
black, and other). There are 38,732 subjects available for analysis; however, because IPCW-HARE 
is computationally intensive, we have elected to use four random sub-samples (n = 1, 000 from each 
dialysis x diabetes status category) for this illustration. The reason for this really rests more in the 
need to compute standard errors via bootstrap thari it does in fitting the model itself. A comparison of 
summary statistics between these sub-samples and the entire data set indicates that our subsamples are 
representative samples. 
For this analysis we focus on estimating mean lifetime dialysis costs for various patient profiles; for 
example, 66-70 year old diabetic white males on hemodialysis vs. 66-70 year old diabetic white males 
on peritoneal dialysis. We have truncated the time scale to 4 years (i.e., L = 4 years) in order to ensure 
that our "probability of censoring" weights remain positive. Hence we are really estimating the four-year 
costs for different modes of dialysis. Since nearly 80% of dialysis patients survive less than four years 
(USRDS, 1999), we still refer to this estimate as the mean lifetime cost. 
The data were stratified by dialysis modality and diabetic status and then analyzed separately. Within 
each strata, our regression model was fit using the following dichotomous covariates: gender, middle-old 
(71-75), old-old(> 75), black, with the respective baseline categories taken to be male, 66-70, and white. 
For this analysis, the race category "other" is excluded; in each case these patients comprise less than 
5% of the sample, and even less in terms of the number of deaths. Since all covariates are dichotomous, 
splines are being fit to costs only, with interactions between pairs of covariates and with cost being 
selected adaptively. The standard deviation of the resulting point estimates were approximated using 
1000 bootstrap samples. 
Table 7 summarizes the results of this analysis, and certain interesting patterns emerge. For example, 
at all reported age/race combinations, blacks exhibit higher average treatment costs than whites; also, 
controlling for diabetic status, hemodialysis is more costly than peritoneal dialysis. Generally, lifetime 
treatment costs do not appear to differ much by gender, and no clear trend emerges for the costs of 
treating diabetic versus non-diabetic patients. The estimated bias of these point estimates, obtained via 
bootstrap approximation, ranges from -$10,000 to $14,000 for hemodialysis point estimates and from 
-$4,400 to $11,700 for peritoneal dialysis point estimates. Except for black hemodialysis patients, his-
tograms of these mean estimates were observed to be unimodal and approximately normally distributed. 
The lack of multimodality indicates that estimated covariate effects largely remained stable across the 
bootstrap iterations. The mean estimates for black hemodialysis patients were bimodal, the second mode 
being centered closer to the average cost for their white counterparts. Consequently, the differences in 
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liftime cost observed by race in hemodialysis patients may be somewhat overstated. 
Two interesting trends identified by the above analysis are that hemodialysis tends to be more costly 
compared to peritoneal dialysis and that black patients tend to be more costly than white patients. How-
ever, the above analysis does not elucidate whether this difference is due to differences in survival times 
by modality or race, different baseline health measures on these patients, or whether e.g. hemodialysis 
is simply more costly. One way of standardizing lifetime costs to better compare hemodialysis versus 
peritoneal dialysis is to compute a cost-effectiveness ratio (CER). For a given mode of dialysis, the 
numerator of the CER represents some functional of lifetime cost; correspondingly, the denominator 
is a corresponding measure of treatment effectiveness (e.g. survival or quality-adjusted survival). See 
Siegel, Laska, and Meisner (1996) for a review of methods used in the economic appraisal of health care 
interventions. 
We calculated CERs to evaluate the relative effectiveness of hemo- versus peritoneal dialysis for various 
subgroups of patients aged 66-70 years. We respectively computed the estimated mean lifetime cost and 
survival time (i.e., measured in months, and truncated at 4 years) using IPCW-HARE (see Table 7) and 
HARE; the results are shown in Table 8. Each CER thus represents "the average cost of dialysis per 
additional month of life with treatment." For the sake of comparison, we also computed and report CERs 
using median costs and survival in Table 8. Controlling for diabetic status, one tentative conclusion from 
this analysis is that peritoneal dialysis is in general less costly than hemodialysis for dialysis patients 
aged 66-70 years old. For example, the average additional cost per month of life for hemodialysis 
patients is $1065 for diabetics and $520 for nondiabetics, the differences in medians being somewhat 
lower. The trends observed by race in Table 7 are now less evident, due largely to the fact that black 
ESRD patients tend to live longer than white ESRD patients. Adjusting for survival differences, Table 
8 in fact suggests that the median cost per month of life for treating white patients may exceed that 
for black patients, especially among hemodialysis patients. Finally, controlling for modality, another 
trend emerging from Table 8 is that diabetics tend to be more costly to treat than nondiabetics. For 
example, the additional average cost per month of life for diabetic patients is $665 for hemodialysis 
patients and $120 for nondiabetics. Importantly, this rudimentary cost-effectiveness analysis does not 
account for variability in the point estimates used in constructing these ratios, and one must be careful 
not to overinterpret these results. A more formal cost-benefit analysis might proceed from here with the 
computation of confidence intervals. Laska, Meisner, and Siegel (1997) give a review of methods in this 
area; a rather novel approach to evaluating CERs is described in Cook and Heyse (2000). 
15 
5 Discussion 
The HARE model (1) is able to incorporate patient covariates while avoiding restrictive assumptions 
on their relationship to cost. We have established the utility of incorporating an IPCW weighting 
scheme into HARE for the purposes of dealing with censored lifetime medical cost data. By upweighting 
completely observed individuals, we are able to account for the informatively censored nature of the cost 
data, and at the same time avoid restrictive assumptions on the relationship between costs, survival, and 
covariates. This approach is quite useful in cases where understanding the cost structure is desirable for 
one or more covariate patterns, but less so for marginal analyses (i.e., V alone). Regarding the latter, 
reasonably efficient nonparametric estimators for functionals of the marginal cost distribution can be 
easily constructed; see, for example, van der Laan and Hubbard (1999), Bang and Tsiatis (2000b), or 
Strawderman (2000). However, one must impose further structure in order to model the conditional 
distribution [VIZ]. IPCW-HARE facilitates this with its highly data-adaptive capabilities, and our 
simulation studies show that it performs quite well in a variety of settings for fixed covariate patterns. 
The addition of the IPCW weights into the HARE score equation necessitated substantial modification 
of the HARE fitting procedures. In large part, these changes were required in order to cope with the 
fact that one is no longer working within a maximum likelihood setting. From a practical point of view, 
these changes enhanced the robustness of fitting procedures, and in particular were found to substantially 
reduce the incidence of "overfitting". The decision to compute the matrix Q assuming K(·l·) is known 
was made primarily for practical reasons. Our simulation results indicate that the resulting estimators 
perform well. Limited comparisons suggest that the major consequence of estimating Q assuming K(·l·) 
is known rather than estimated is a slightly larger model. This appears to result from differences in 
the magnitude of the penalty term in the corresponding AICR statistic. Further research on the most 
appropriate criterion for model selection, as well as alternative methods for adaptively building models, 
is needed. Some recent work by Sin and White (1996) on more general Kullback-Leibler-based model 
selection criteria may prove useful here. 
IPCW-HARE has a number of useful advantages over existing regression methods, many of which can 
be traced to the absence of restrictive parametric assumptions on the joint distribution of (V, T, Z). 
However, despite encouraging results, there are still some important practical limitations. Few of these 
are actually limitations of HARE itself, as we explain below. Major issues to consider when using this 
methodology include (i) the potential inefficiency of using only the data from complete cases; (ii) the 
unspecified dependence of the response variable V on T; (iii) the need to specify a model for the censoring 
mechanism; and, (iv) the failure to use the history of the cost process, if available. 
We may handle the problem (i) by augmenting the IPCW-HARE estimating function to include ad-
ditional information on censored subjects. Intuitively, adding any function of the censored cost data 
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with mean zero is a possible choice; the key is to select it so as to achieve a significant reduction in 
variability. Adjusting the IPCW-HARE estimating function in this manner would substantially increase 
the computational complexity of IPCW-HARE, and we will not attempt to explore these issues further 
here. In-depth discussions of such adjustments in related problems can be found in Rotnitzky, Robins 
and Scharfstein (1998) and Scharfstein, Robins, and Rotnitzky (1999). 
The problem in (ii) stems from the unspecified dependence of V on T, which makes it difficult to 
assess whether the difference between, say, E[VJZ = z1] and E[VJZ = z2] is really due to differences 
in cost, differences in survival, or both. This is a direct result of the choice to model [VJZ] instead of 
[V, TJZ], a drawback not unique to this paper. Indeed, essentially all papers on this topic referenced 
here take this same point of view. In our example we used CERs to partially address this difficulty in 
interpretation. More formally, this problem might be addressed by modeling the conditional distribution 
[V, TJZ] = [VJT, Z][TJZ]. In fact, including T as a covariate in the present implementation of IPCW-
HARE appears to pose no fundamental difficulty with the theory, and consequently one could alleviate 
this difficulty in interpretation by adjusting cost comparisons to a common survival time. Moreover, 
HARE could be used to model [TJZ], keeping with our goal of making as few parametric assumptions 
as possible on (V, T, Z). 
The difficulty with (iii) is that, outside certain favorable settings (e.g., a randomized trial with only 
administrative censoring), the true censoring process is unknown. The importance of this rests in the 
fact that IPCW-HARE requires the correct model for censoring probabilities. Gross misspecification 
of these will certainly produce estimators whose properties are as questionable as those produced by 
standard survival techniques. However, the modeling burden must be placed somewhere. We have 
chosen to place this burden on the censoring process, a practice with significant value that has been 
established in numerous previous papers of Robins and his coauthors. 
Finally, the problem with (iv) relates to the fact that our model only uses the cumulative cost at a 
patient's last follow-up or death time to build the distribution of lifetime cost. Models that incorporate 
aspects of a patient's entire cost history (e.g. monthly dialysis costs) will yield a richer, more complete 
picture of the lifetime cost distribution. Lin (2000b) and Bang and Tsiatis (2000a) propose handling this 
in much the same way, namely by considering a fixed partition of the time scale. Variations on IPCW-
HARE could presumably be used in this setting as well. However, such approaches seem inefficient in 
general, since they do not utilize the possible correlation between cost increments across different time 
intervals. Methods for incorporating this information are a subject of ongoing research. 
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Table 1: Bias of Estimates for pt Cost Paradigm 
IPCW-HARE Original HARE Linear 
True Cost PH=F PH=T PH=F PH=T Regression 
Mean: Z=25 $30,861 -$468 -$542 -$1,746 -$1,753 $83 
Median: Z=25 $31,640 -$50 -$78 -$1,376 -$1,369 $116 
Mean: Z=35 $34,396 -$157 -$198 -$1,873 -$1,873 -$69 
Median: Z=35 $35,265 $162 $136 -$1,560 -$1,556 -$15 
Mean: Z=45 $37,745 $14 $28 -$1,841 -$1,837 -$34 
Median: Z=45 $38,726 $205 $200 -$1,649 -$1,649 $18 
Mean: Z=55 $41,121 $224 $277 -$1,795 -$1,788 -$26 
Median: Z=55 $42,206 $290 $301 -$1,737 -$1,739 $32 
Mean: Z=65 $44,605 $112 $201 -$1,819 -$1,800 -$126 
Median: Z=65 $45,773 $0 $33 -$1,920 -$1,926 -$41 
Caption Table 1: Simulation consists of 2000 data sets, each with n=200. We use the Cox proportional 
hazards model to estimate K(.). "PH=" T: a proportional hazards model, F: covariate-by-cost inter-
actions are allowed. The "true cost" is empirically obtained from a data set of size n =30,000 with 
the specified covariate pattern. The results in the "Linear Regression" column respectively correspond 
to the estimators of Lin (2000b) (rows labelled "mean") and Bang and Tsiatis (2000a) (rows labelled 
"median"). 
Table 2: Standard deviations under 1st Cost Paradigm 
IPCW-HARE Original HARE Linear 
True Cost PH=F PH=T PH=F PH=T Regression 
Mean: Z=25 $30,861 $1,907 $1,798 $1,194 $1,194 $1,161 
Median: Z=25 $31,640 $1,924 $1,824 $1,208 $1,209 $1,349 
Mean: Z=35 $34,396 $1,265 $1,303 $957 $959 $794 
Median: Z=35 $35,265 $1,240 $1,278 $945 $944 $919 
Mean: Z=45 $37,745 $1,213 $1,242 $1,021 $1,028 $681 
Median: Z=45 $38,726 $1,207 $1,237 $1,032 $1,037 $771 
Mean: Z=55 $41,121 $1,335 $1,384 $1,172 $1,177 $920 
Median: Z=55 $42,206 $1,357 $1,405 $1,229 $1,242 $1,034 
Mean: Z=65 $44,605 $2,070 $2,077 $1,617 $1,624 $1,333 
Median: Z=65 $45,773 $2,071 $2,106 $1,703 $1,715 $1,507 
Caption Table 2: Empirical standard deviations over 2000 simulated datasets corresponding to Table 1. 
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Table 3: Bias of Estimates for 2nd Cost Paradigm 
IPCW-HARE Linear 
True Cost PH=F PH=T Regression 
Mean: Z=(15,0) $20,386 $511 -$1,053 -$1,410 
Median: Z=(15,0) $17,984 $1,472 $2,194 $172 
Mean: Z=(15,1) $25,452 -$1,062 -$2,089 -$1,685 
Median: Z=(15,1) $23,076 -$338 -$1,283 $146 
Mean: Z=(30,0) $38,614 -$3 $346 $2,183 
Median: Z=(30,0) $35,368 -$795 -$1,370 $4,155 
Mean: Z=(30,1) $43,695 -$866 -$1,527 $1,894 
Median: Z=(30,1) $40,595 $230 -$260 $3,995 
Mean: Z=(45,0) $64,305 $244 $817 -$1,687 
Median: Z=(45,0) $65,267 -$189 $501 -$4,375 
Mean: Z=(45,1) $69,143 $67 -$1,216 -$1,733 
Median: Z=(45,1) $70,206 -$504 -$1,677 -$4,248 
Caption Table 3: Simulation consists of 2000 data sets, each with n =200. We use the Cox propor-
tional hazards model to estimate K(.). "PH=" T: a proportional hazards model, F: covariate-by-cost 
interactions are allowed. The "true cost" is empirically obtained from a data set of size n =30,000 with 
the specified covariate pattern. The results in the "Linear Regression" column respectively correspond 
to the estimators of Lin (2000b) (rows labelled "mean") and Bang and Tsiatis (2000a) (rows labelled 
"median"). The censoring percentages for z1 = 15, 30, and 45 are approximately 20%, 35%, and 45%, 
respectively. 
Table 4: Standard Deviations for 2nd Cost Paradigm 
IPCW-HARE Linear 
True Cost PH=F PH=T Regression 
Mean: Z=(15,0) $20,386 $2,090 $2,159 $3,196 
Median: Z=(15,0) $17,984 $1,801 $1,787 $2,601 
Mean: Z=(15,1) $25,452 $2,808 $2,867 $4,541 
Median: Z=(15,1) $23,076 $2,561 $2,522 $4,458 
Mean: Z=(30,0) $38,614 $3,311 $3,422 $3,012 
Median: Z=(30,0) $35,368 $3,912 $3,962 $4,096 
Mean: Z=(30,1) $43,695 $4,247 $4,688 $4,440 
Median: Z=(30,1) $40,595 $4,964 $5,501 $5,196 
Mean: Z=(45,0) $64,305 $6,472 $7,455 $5,789 
Median: Z=(45,0) $65,267 $7,920 $8,460 $7,799 
Mean: Z=(45,1) $69,143 $8,199 $8,928 $6,662 
Median: Z=(45,1) $70,206 $9,047 $9,709 $8,256 
Caption Table 4: Empirical standard deviations over 2000 simulated datasets corresponding to Table 3. 
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Table 5: Bias of Estimates for 3rd Cost Paradigm 
IPCW-HARE Linear 
True Cost PH=F PH=T Regression 
Mean: Z=(15,0) $1,309 -$91 -$63 $1,422 
Median: Z=(15,0) $1,432 -$210 -$203 $988 
Mean: Z=(15,1) $327 -$13 -$23 -$1,5791 
Median: Z=(15,1) $356 -$43 -$56 -$658t 
Mean: Z=(30,0) $4,840 -$39 -$147 $462 
Median: Z=(30,0) $5,173 -$343 -$543 -$932 
Mean: Z=(30,1) $1,212 -$36 -$30 $107 
Median: Z=(30,1) $1,295 -$110 -$134 $224 
Mean: Z=(45,0) $9,558 $349 $74 -$1,684 
Median: Z=(45,0) $9,930 -$76 -$304 -$3,868 
Mean: Z=(45,1) $2,388 $19 $66 $1,503 
Median: Z=(45,1) $2,481 -$11 -$59 $858 
Caption Table 5: Simulation consists of 2000 data sets, each with n =200. We use the Cox propor-
tional hazards model to estimate K(.). "PH=" T: a proportional hazards model, F: covariate-by-cost 
interactions are allowed. The "true cost" is empirically obtained from a data set of size n =30,000 with 
the specified covariate pattern. The results in the "Linear Regression" column respectively correspond 
to the estimators of Lin (2000b) (rows labelled "mean") and Bang and Tsiatis (2000a) (rows labelled 
"median"). The censoring percentages for ( z1, z2) read from the top to the bottom of this table are 
respectively 49. 40, 44, 35, 34, and 28%. Bias estimates marked with a t correspond to a negative 
simulated average cost (mean or median). 
Table 6: Standard Deviations for 3rd Cost Paradigm 
IPCW-HARE Linear 
True Cost PH=F PH=T Regression 
Mean: Z=(15,0) $1,309 $169 $156 $308 
Median: Z=(15,0) $1,432 $185 $172 $574 
Mean: Z=(15,1) $327 $44 $40 $389 
Median: Z=(15,1) $356 $49 $45 $420 
Mean: Z=(30,0) $4,840 $505 $473 $446 
Median: Z=(30,0) $5,173 $573 $544 $518 
Mean: Z=(30,1) $1,212 $130 $120 $176 
Median: Z=(30,1) $1,295 $145 $130 $147 
Mean: Z=(45,0) $9,558 $1,154 $1,046 $737 
Median: Z=(45,0) $9,930 $1,230 $1,195 $681 
Mean: Z=(45,1) $2,388 $270 $259 $389 
Median: Z=(45,1) $2,481 $314 $277 $352 
Caption Table 6: Empirical standard deviations over 2000 simulated datasets corresponding to Table 5. 
22 
Table 7: Mean 4-Year Costs for Various USRDS Subgroups; 66-75 years old 
Race and Hemodialysis Peritoneal Dialysis 
Gender Diabetic Non-diabetic Diabetic Non-diabetic 
White Male $142,900 $125,562 $105,369 $114,133 
(10,423) (7,567) ( 4,405) (7,300) 
Black Male $161,011 $147,759 $132,847 $132,751 
66-70 (16,930) (16,322) (9,867) (14,069) 
years old White Female $144,042 $124,891 $103,910 $112,262 
(11,080) (7,158) (3,933) (7,418) 
Black Female $160,843 $148,205 $134,043 $132,788 
(15,647) (16,389) (9,628) (14,171) 
White Male $120,977 $125,838 $105,430 $112,041 
(11,721) (6,744) (5,020) (4,932) 
Black Male $141,727 $149,886 $133,481 $132,918 
71-75 (15,999) (15,178) (10,800) (13,503) 
years old White Female $124,005 $125,527 $106,594 $113,072 
(10,050) (6,005) (4,402) (5,654) 
Black Female $142,219 $148,195 $133,614 $132,337 
(13,533) (15,707) (10,286) (13,654) 
Caption Table 7: Estimated mean costs obtained using IPCW-HARE. Numbers in parenthesis are stan-
dard errors based on 1000 bootstrap replications. Censoring percentages by column are approximately 
20%, 24%, 17%, and 12%. 
Table 8: CERs Based on Means and Medians for Various USRDS Subgroups 66-70 years old 
Race and Hemodialysis Peritoneal Dialysis 
Gender Diabetic Non-diabetic Diabetic Non-diabetic 
White Male $5,309 $4,396 $4,104 $3,921 
Mean Black Male $5,149 $4,590 $4,095 $4,062 
CER White Female $5,179 $4,386 $4,025 $3,843 
Black Female $4,980 $4,587 $4,132 $4,054 
White Male $4,688 $4,002 $3,646 $3,481 
Median Black Male $4,153 $3,305 $3,574 $3,214 
CER White Female $4,338 $4,002 $3,646 $3,481 
Black Female $3,915 $3,305 $3,574 $3,214 
Caption Table 8: For each USRDS subgroup and covariate pattern, the mean cost-effectiveness ratio 
(CERs) is computed by taking the appropriate entry from Table 7 and dividing it by the corresponding 
average survival time, measured in months and truncated at 4 years. Median CERs are computed 
similarly (median costs and survival for these subgroups not shown). 
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6 Technical Appendix 
Proposition 1 Suppose that K(XIZ) > 0 with probability one. Further, assume P{A/K(XIZ) > 
0} > 0 and SUPu,z IR(uiz)- K(uiz)l ~ 0. Then, with probability tending to one, there exists a unique 
~ ~ p 
solution f3 such that f3 -+ /3*, where /3* E IRP is the unique maximizer of the strictly concave function 
E[t'1 (/3)] with t'1 (/3) being given by (3). 
Proof of Proposition 1: 
Andersen and Gill (1982) make use of concave function theory to prove consistency of the regression 
parameter under Cox's proportional hazards model. The HARE model, for a fixed set of basis functions, 
has a nice exponential family structure that allows direct use of Theorem ILl and Corollary II.2 of 
Andersen and Gill (1982) for proving consistency of the p-dimensional solution vector (j. 
Let B be any open convex subset of IRP and define 
The exponential family structure of the HARE model (see e.g. Kooperberg et al., 1995a, §3) ensures 
the likelihood contributions t'i(/3), i = 1 ... n are concave functions of f3 E E. The assumptions of the 
proposition imply that, with probability tending to one, the weights Wi = Ai/ K(XiiZi), i = 1 ... n are 
nonnegative, finite, and such that Wi > 0 for at least some i. It follows that H(/3) forms a random 
sequence of concave functions in f3 E B (cf. Hiriart-Urruty and Lemarechal, 1996, Proposition 2.1.1). 
Moreover, for each f3 E B, H(/3) ~ E[t'1 (/3)], wh~re E[t'I(/3)] is itself concave. Hence, by Theorem ILl 
of Andersen and Gill, sup/3EB IH(/3)- E[t'I(/3)]1 ~ 0 for any compact set B C E. 
The results of Kooperberg et al. (1995b) imply that E[t'1 (/3)] has a unique maximum at f3 = (3*. Since 
our choice of B above is in fact arbitrary, let B be chosen such that /3* E B C B. Then, since 7J maximizes 
H(/3), it follows by Corollary II.2 of Andersen and Gill (1982) that 7J ~ /3*, proving the desired result. 
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Proposition 2 Suppose the hazard function for censoring follows the Cox proportional hazards model 
>.c(uiz) = >.0c(u)exp{rJ'z}. Forthe data (Xi,l-Ai,Zi)i = 1. . . n, let::Y and Aoc(t) be obtained in the 
usual manner, and assume the conditions of§ VII.2.2 of Andersen et al. {1993} hold. Then, 
n 
.;nsipcw(/3*) = n-1/ 2 L ¢(Yi, xi, Ai, Zi, (3*' 1'o) + Op(l) 
i=l 
where 
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Mf(u) = J{X; :S u,~; = 0}- lou I{Xi ~ s}A.c(siZ;)ds, 
and g(u, V;, T;, Z;, (3*, "Yo) is given in (16}. 
Proposition 3 Consider the same setting as Proposition 2. Let S~vcw ((3) denote the derivative of 
Sipcw(f3) with respect to (3, and suppose that -S~pcwU3*) ~ M(/3*), where M = M(/3*) is nonsingu-
lar. Then, 
vn(73-!3*) 4 N(o,M-1QM-1 ) 
for Q = E[w(Y, X,~' Z, (3*, /'o)wT(Y, X,~' Z, (3*, /'o)]. In particular, with v02 = vvT for any vector v, 
Q = E [{SI(/3*)}02] - to {wo(u,/3* ,/'o)}02 dAoc(u)- Ah-l AT (8) 
K(TIZ) Jo so(u,/'o) 
where h-1 is the asymptotic variance of fo(-;y- "Yo) and so(u, "Yo), A = A(/3*, "Yo) and w0(u, (3*, "Yo) are 
respectively defined in ( 13 )- ( 15). 
REMARK: The matrix Q is derived directly from (7). Using the fact that Mf (·), i = 1. .. n are 
orthogonal local square-integrable martingales with respect to a conveniently defined filtration (e.g., 
see Zhao and Tsiatis, 1997), the calculations involve simple and well-known variance and covariance 
identities for martingales. Estimation of Q may be carried out using appropriate approximations for 
each of the terms in (8). However, to ensure positive definiteness, it is preferable to compute Q via 
n-1 "LJ$i;f'[, where ;f; is obtained from (7). In either case, the functions w0(u,(3*,/'o) and matrix 
A(/3*, "Yo) must be recomputed every time a basis function is added or deleted during the model building 
phase. 
REMARK: The results in Propositions 2 and 3 in no way depend on S;(/3) being the particular full data 
score derived under model (1). In fact, these asymptotic representations continue to apply to any mean 
zero function of the full data having finite variance, provided K (·I·) is estimated via a Cox model. Hence, 
for example, our results contain those of Lin (2000b) for a single time interval as a special case. 
Proof of Proposition 2: 
We suppose Z is q x 1 and f3 is p x 1. Also, for any vector v, we let v00 = 1, v01 = v, and v02 = vvT. 
We may write 
~ ~; = ~i _ ~ ~; (K(XiiZi) _ 1) . 
K(X;IZi) K(XiiZi) K(XiiZi) K(XiiZi) (9) 
As pointed out in Andersen et al. (1993, §VII.2.3), there are a variety of different, yet asymptotically 
equivalent, ways to estimate K(·lz) based on -;y and Aoc(t). Let us assume K(·iz) is estimated as in 
(7.2.34) of Andersen et al. (1993); then, employing the Duhamel equation (cf. Andersen et al., 1993, 
eqn. 2.6.5), 
(10) 
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where Li(u) = Ac(uiZi)- Ac(uiZi), Ac(siZi) = Aoc(s) exp{::yT Zi}, Ac(siZi) = Aoc(s) exp{!'J' Zi}, and 
Ri(u) = I{Xi ~ u}. Using (9) and (10), we thus find 
(11) 
Using results in Andersen et al. (1993, pp. 503-506), it is not difficult to establish that, for a given 
Z = z* and t > 0, the following expansion holds for Ac(tlz*)- Ac(tlz*): 
where 
J(t,')'o,z*) = exp{'yg' z*} ( (z*- 81 ~u,')'o~) dA0c(u), lo so u,')'o 
(13) 
and M0 (u) = "L.j=1 M{(u) for M{(u) = I{Xj:::; u,6.j = 0}- J0uYj(s)dAc(s1Zj)· Substituting (12) 
into (11) (i.e., with z* = Zi) and rearranging terms, 
. * __ 1 ~ 6.iSi(f3*) ~(~ ) -1 ~ roo [ -1 ~ ·( . * l dMf(u) -1/2 
S,pcw(f3 ) - n ~ K(XiiZi) +A ')'- ')'o + n ~ Jo n ;;;. ~1 u)S3 ((3 ) so(u, "Yo) + op(n ) 
where 
APXQ = roo [n-1 t~i(u)Si(/3*) (zi- 81 (U,')'o))T] dAoc(u). 
lo i=1 so(u,')'o) 
and 
6,.i T ~i(u) = K(XiiZi) Ri(u) exp{/'0 Zi}· 
Let b(V, T, Z) be any bounded function of the full data vector (V, T, Z). Then, since 6.! {X ~ u} = 
6.! {T ~ u }, it is easy to show that 
E[~(u)b(V,T,Z)] = E[I{T ~ u}exp{'yg'Z}b(V,T,Z)], 
and hence that 
~i, In-' t,<;(u)b(V;,T;, Z;)- E[I{T 2 u}exphfZ}b(V,T, Z)]l !; 0 
(e.g., Pollard, 1990, Theorem 8.3). Thus, 
S . ((3*) _ -1 ~ [ 6.i S·(f3*) roo Wo(u,(3* ,')'o)dMc( )] A(~_ ) ( -1/2) 
tpcw - n ~ K(XiiZi) • + Jo so(u,')'o) i u + ')' ')'o + Op n ' 
where A= Apxq(.B*,')'o), 
APXQ((3*,')'o) = roo (w1(u,(3*,')'o) -wo(u,(3*,')'o) 8rt,')'oj) dAoc(u), 
lo so u,')'o 
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(14) 
and 
(15) 
Finally, since 
(cf. Andersen et al., 1993, §VII.2.2), it follows that 
n 
..fii,Sipcw(f3*) = n-l/2 .2::: '1/J(}i, xi, Ai, zi, j3*' 'Yo)+ Op(l) 
i=l 
where 
with 
( Tr T z j3* ) wo(u,j3*,'Yo) A(j3* )"-1( ) (z sl(u,')'o)) g u, vi, i, i, , 'Yo = ( ) + , 'Yo L.. 'Yo i - ( ) . 
so u, 'Yo so u, 'Yo 
(16) 
Noting that 
Ai _ 1 _ { 00 dMf(u) 
K(XiiZi) - } 0 K(uiZi) 
(e.g., Strawderman, 2000, Lemma 1), one may rewrite the contribution of individual i as 
a form useful for variance calculations ( cf. Zhao and Tsiatis, 1997). 
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